接受免疫抑制治疗的肾移植受者对帕博利珠单抗的完全肿瘤缓解及同种异体移植肾的保留 - Suppr

Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy.

作者信息

Sadaat Masood, Jang Sekwon

机构信息

Inova Schar Cancer Institute, Fairfax, VA.

出版信息

J Oncol Pract. 2018 Mar;14(3):198-199. doi: 10.1200/JOP.2017.027326. Epub 2017 Dec 19.

DOI:10.1200/JOP.2017.027326

PMID:29257718

Abstract

摘要

相似文献

Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy.

J Oncol Pract. 2018 Mar;14(3):198-199. doi: 10.1200/JOP.2017.027326. Epub 2017 Dec 19.

The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma.

Melanoma Res. 2020 Jun;30(3):321-324. doi: 10.1097/CMR.0000000000000651.

Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation.

JCO Oncol Pract. 2020 Mar;16(3):137-138. doi: 10.1200/JOP.19.00567. Epub 2019 Nov 26.

Checkpoint blockade after kidney transplantation.

Eur J Cancer. 2018 Jun;96:111-114. doi: 10.1016/j.ejca.2018.03.019. Epub 2018 Apr 26.

Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus.

Clin Exp Dermatol. 2022 Mar;47(3):608-609. doi: 10.1111/ced.15018. Epub 2021 Dec 11.

Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases.

Transplant Proc. 2012 Nov;44(9):2824-6. doi: 10.1016/j.transproceed.2012.09.025.

Vitiligo-like lesions located over In-transit metastases of malignant melanoma as a clinical marker of complete response to pembrolizumab.

Dermatol Online J. 2019 Dec 15;25(12):13030/qt8d3818j5.

Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient.

Transplantation. 2017 Sep;101(9):e291. doi: 10.1097/TP.0000000000001861.

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.

J Immunother Cancer. 2016 Oct 18;4:64. doi: 10.1186/s40425-016-0171-8. eCollection 2016.

The evolving role of sirolimus in renal transplantation.

QJM. 2003 Jun;96(6):401-9. doi: 10.1093/qjmed/hcg072.

引用本文的文献

Immune Checkpoint Inhibitors and Allograft Rejection Risk: Emerging Evidence Regarding Their Use in Kidney Transplant Recipients.

J Clin Med. 2025 Jul 20;14(14):5152. doi: 10.3390/jcm14145152.

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies.

Front Transplant. 2023 Oct 30;2:1284740. doi: 10.3389/frtra.2023.1284740. eCollection 2023.

Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.

J Clin Med. 2022 Jun 11;11(12):3364. doi: 10.3390/jcm11123364.

Immunotherapy for Non-melanoma Skin Cancer.

Curr Oncol Rep. 2021 Aug 27;23(11):125. doi: 10.1007/s11912-021-01120-z.

Application of Immune Checkpoint Inhibitors in Solid Organ Transplantation Recipients: A Systematic Review.

Interdiscip Sci. 2021 Dec;13(4):801-814. doi: 10.1007/s12539-021-00437-4. Epub 2021 Jun 21.

Immune checkpoint inhibitors to treat cutaneous malignancies.

J Am Acad Dermatol. 2020 Nov;83(5):1239-1253. doi: 10.1016/j.jaad.2020.03.131. Epub 2020 May 24.

A review of cancer immunotherapy: from the past, to the present, to the future.

Curr Oncol. 2020 Apr;27(Suppl 2):S87-S97. doi: 10.3747/co.27.5223. Epub 2020 Apr 1.

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.

Oncologist. 2020 Jun;25(6):505-514. doi: 10.1634/theoncologist.2019-0659. Epub 2020 Feb 11.

Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients.

Kidney Int Rep. 2019 Dec 7;5(2):149-158. doi: 10.1016/j.ekir.2019.11.015. eCollection 2020 Feb.

Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation.

Nat Commun. 2019 Oct 17;10(1):4712. doi: 10.1038/s41467-019-12628-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献